Related Experiment Video
Updated: Feb 24, 2026

09:17
Quantitative Static and Dynamic Assessment of Balance Control in Stroke Patients
Published on: May 17, 2020
3.9K
TWO AUTOCOVARIANCE-BASED MEASURES OF BALANCE IN PARKINSONIANS AND NORMAL CONTROLS
Gregory M Constantine1, Marius Buliga2, Yoram Vodovotz3
1Department of Mathematics, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Summary
An affordable electronic platform test shows promise for early Parkinson's disease diagnosis. Stiffness and crossing time metrics are explored as key indicators for identifying individuals at risk.
Area of Science:
- Neurology
- Biomedical Engineering
- Diagnostic Technology
Background:
- Parkinson's disease (PD) diagnosis often relies on clinical symptoms that appear after significant neurodegeneration.
- Early detection is crucial for timely intervention and management of Parkinson's disease.
- Current diagnostic methods can be invasive or expensive, limiting widespread early screening.
Purpose of the Study:
- To evaluate the feasibility of using center of pressure (CoP) electronic platform testing as an accessible early diagnostic tool for Parkinson's disease.
- To investigate the utility of specific biomechanical parameters, namely stiffness measures and crossing time, for identifying individuals at risk of PD.
Main Methods:
- Utilized electronic pressure platforms to record center of pressure data during specific tasks.
- Analyzed data to derive quantitative measures of postural sway, including stiffness and crossing time.
- Compared these metrics between at-risk populations and control groups (details not provided in abstract).
Main Results:
- Center of pressure electronic platform testing presents a cost-effective approach for potential early Parkinson's disease screening.
- Stiffness measures and crossing time statistics demonstrate potential as biomarkers for identifying individuals at risk of developing Parkinson's disease.
Conclusions:
- Center of pressure electronic platform testing offers a promising, affordable avenue for early Parkinson's disease risk assessment.
- Further validation of stiffness and crossing time metrics is warranted for clinical application in Parkinson's disease diagnosis.

